Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  infection
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 51 for your search:
Start Over
Phase III Randomized Study of Voriconazole Compared to Liposomal Amphotericin B as Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia (Summary Last Modified 09/1999)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-98-C-0063, PFIZER-150-603
Phase III Randomized Study Comparing Urokinase With Heparin in Preventing Infection and Occlusion in Central Venous Catheters in Children With Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 3 months-21 years
Sponsor: NCI
Protocol IDs: CCG-S921
Phase III Study of Voriconazole in Patients With Invasive Fungal Infections (Summary Last Modified 01/2001)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: NCI-99-C-0094B, NCI-99-C-0094
Phase III Randomized Study of Nystatin in Patients Receiving High Dose Interleukin-2 (Summary Last Modified 07/2000)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 to 65
Sponsor: NCI
Protocol IDs: NCI-99-C-0097
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: 00-085, MSKCC-00085, MERCK-026-01, NCI-G00-1898, NCT00008359
Phase III Prophylactic Passive Immunization Against Infection Utilizing Intravenous Immunoglobulin in Cancer Patients Undergoing Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-83-C-192, NCI-T83-1282N, T83-1282
Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 2 to 12
Sponsor: NCI, NHLBI
Protocol IDs: 416, BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803
American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCCWFU98308, U10CA081851, WFU-07-02-03, NCT00752895
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000633817, P30CA012197, CCCWFU-98608, IRB00007690, NCT00855309
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 13 and over
Sponsor: NCI, Other
Protocol IDs: 1322.00, FHCRC-1322.00, NCI-H99-0030, CDR0000067050, NCT00003883
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1379.00, FHCRC-1379.00, NCI-G01-1929, CDR0000068540, NCT00014391
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: 1603.00, FHCRC-1603.00, NCI-H02-0092, CDR0000256871, NCT00045292
Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 1290.00, FHCRC-1290.00, NCI-G01-1939, CDR0000068593, NCT00016081
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 4 to 21
Sponsor: NCI, Other
Protocol IDs: ACCL1031, NCI-2011-02635, CDR0000695718, COG-ACCL1031, U10CA095861, NCT01305200
Phase I/II Trial of Suramin in Adult Patients with AIDS-Related Kaposi's Sarcoma or Lymphadenopathy Syndrome
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NEDH-AIDS, NCI-T85-0081D, T85-0081
Phase I/II Pilot Study of Amphotericin-B Lipid Complex in the Treatment of Hepatosplenic Candidiasis in Children with Neoplastic Disease
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 2 to 18
Sponsor: NCI
Protocol IDs: NCI-92-C-0047B, NCI-T92-0001N, T92-0001
Anidulafungin in Treating Immunocompromised Children With Neutropenia
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 2 to 17
Sponsor: NCI
Protocol IDs: CDR0000322888, NCI-03-C-0229C, NCT00068471
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, NIH WGMCC
Protocol IDs: 030205, 03-C-0205, CDR0000315356, NCT00064311
Phase II Therapy with Suramin in Adult Patients with AIDS-Related Symptom Complex and Limited AIDS-Related Kaposi's Sarcoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 50
Sponsor: NCI
Protocol IDs: MDA-DM-8486, NCI-T85-0045D, T85-0045
Start Over